Form 4: WisdomTree COO Sells 30,000 Shares in Planned Transaction

WisdomTree's President and COO, R Jarrett Lilien, sold 30,000 shares of common stock for $16.84 per share under a pre-arranged Rule 10b5-1 trading plan.

Summary

• R Jarrett Lilien, President and COO of WisdomTree, Inc. (WT), sold 30,000 shares of common stock.
• The transaction occurred on February 25, 2026, at a price of $16.84 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan established on November 24, 2025.
• Following the sale, Lilien beneficially owns 1,140,245 shares of WisdomTree common stock.
• This beneficial ownership includes restricted stock awards vesting on January 25, 2027 (114,570 shares), January 25, 2028 (59,724 shares), and January 25, 2029 (23,785 shares).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While it's an insider sale, its execution under a 10b5-1 plan mitigates concerns of opportunistic selling, and the executive retains significant equity.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 trading plan, indicating a planned and orderly transaction rather than an opportunistic one.
• The reporting person still retains a significant beneficial ownership of 1,140,245 shares, including substantial restricted stock awards.

Negatives

• An insider sale, even if planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake.

Future Outlook

The filing indicates future vesting of restricted stock awards for R Jarrett Lilien on January 25, 2027 (114,570 shares), January 25, 2028 (59,724 shares), and January 25, 2029 (23,785 shares), suggesting continued long-term equity alignment.

Management Comments

• The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 24, 2025.
• Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
• All sales by the reporting person are subject to the Issuer's equity ownership requirements.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 plans are common practice for executives to manage personal finances while adhering to insider trading regulations. Such planned sales typically carry less negative market signal than unplanned, opportunistic sales.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the planned sale as a routine financial management activity by an executive, but some might interpret any insider selling as a slight negative signal, despite the 10b5-1 plan.

Next Steps

• Vesting of 114,570 restricted stock awards on January 25, 2027.
• Vesting of 59,724 restricted stock awards on January 25, 2028.
• Vesting of 23,785 restricted stock awards on January 25, 2029.

Key Dates

Recommendation

While an insider sale occurred, it was pre-planned under a Rule 10b5-1 plan, which reduces the negative implications typically associated with insider selling. The executive retains a substantial equity stake, including future restricted stock awards. This single transaction does not provide sufficient new information to warrant a change in investment thesis, suggesting a 'hold' position is appropriate.

Keywords

WisdomTree, WT, Insider Trading, Form 4, R Jarrett Lilien, Stock Sale, Rule 10b5-1, Executive Compensation, Common Stock